Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Global Pharmaceutical Sales Expected To Reach $880 billion in 2011

This article was originally published in The Pink Sheet Daily

Executive Summary

IMS Health says the pharmaceutical industry will do better in 2011 than it is doing this year, but a full rebound is not on the horizon, as generics and payor restrictions continue to take a toll.

You may also be interested in...

Cost Of Drug Treatment In Medicare's Top Therapeutic Areas Dropping Quickly With Generics, IMS Data Show

IMS exec says average cost per day of drug treatment in top 10 Part D drug classes will drop to about 50¢ a day by 2014.

IPO Update: Patheon Public Once Again, Audentes To Move Into The Clinic

Two companies in the biopharma space began trading publicly this week, one to pay off debt, the other to fund an early-stage pipeline.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts